Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Immunology  |  Ophthalmology  |  Rheumatology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Sjogren's Syndrome Clinical Trials

A listing of Sjogren's Syndrome medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (36) clinical trials

Winthrop University Hospital Clinical Trials Center in conjunction with The Division of Rheumatology and The Arthritis and Rheumatic Disease Center is conducting a clinical research study on an investigational medication, for patient with dry mouth associated with SjÖgren’s Syndrome. This study will evaluate the safety and effectiveness of an investigational ...

Phase N/A

NYU Winthrop Hospital Clinical Trials Center in conjunction with The Division of Rheumatology and The Arthritis and Rheumatic Disease Center is conducting a clinical research study on an investigational medication, for patient with dry mouth associated with SjÖgren’s Syndrome.

Phase N/A

The objective of this study is to evaluate the efficacy and safety of two strengths of Lacripep™ ophthalmic solution versus placebo administered 3 times a day for 4 weeks with subjects with Dry Eye associated with Primary Sjögren’s Syndrome

Phase

A pilot study looking at ultrasound measure in Sjogren's Syndrome patients

Phase

Synexus is conducting a Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Targeted Anti-Inflammatory Therapies in Adult Subjects with Active Sjogren’s Syndrome.

Phase

Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS). This study will determine the dose-response relationship of VAY736 for key efficacy and safety parameters.

Phase

Primary Outcome Measures: Proportion of participants with a 1 point or greater change on the salivary gland ultrasound (SGUS) score for parotid and submandibular glands [ Time Frame: Week 4 and Week 12 ] To determine the impact of INCB050465 on salivary gland echostructure. Secondary Outcome Measures: Change from baseline ...

Phase

An Open-Label Phase 2 Study of INCB050465 in Participants With Primary Sjögren's Syndrome  

Phase

To determine the impact of INCB050465 on the signs and symptoms of Sjögren's syndrome (SS). To evaluate the safety and tolerability of INCB050465.  

Phase